Wells Fargo’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
RCM
ACA
Wells Fargo's ASND Position: Q1 2026 in Review
Wells Fargo increased its Ascendis Pharma A/S (ASND) stake by 356% in Q1 2026, buying an estimated $27M and bringing the position to 154,199 shares worth $35.3M. The position accounts for 0.01% of the portfolio, ranked #1154.
Wells Fargo first reported a position in ASND in Q1 2015 and has held it in 39 quarters since. The position peaked at $55.2M in Q3 2021. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.
- Wells Fargo held 154,199 shares of Ascendis Pharma A/S worth $35.3M as of Q1 2026.
- Wells Fargo bought 120,419 Ascendis Pharma A/S shares in Q1 2026, an estimated $27M.
- Ascendis Pharma A/S made up 0.01% of Wells Fargo's portfolio in Q1 2026, its #1154 holding.
- Wells Fargo first reported a position in Ascendis Pharma A/S in Q1 2015 and has held it in 39 quarters since.
- Wells Fargo's Ascendis Pharma A/S position peaked at $55.2M in Q3 2021.
- 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.